Borregaard ASA BRG
Oslo Børs · Basic Materials · Specialty Chemicals
Keep this stock on your watchlist and set email alerts for prices, reports and important announcements where available.
Annual accounts for Borregaard
| NOK million | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | 6,776 | 7,024 | 7,502 | 7,580 |
| EBITDA | 1,655 | 1,785 | 1,833 | 1,617 |
| Net income | 892 | 870 | 823 | 620 |
| Balance sheet | ||||
| Equity | 4,394 | 4,855 | 5,041 | 5,853 |
| Total debt | 2,072 | 2,262 | 2,323 | 2,181 |
| Cash | 234 | 469 | 82 | 90 |
| Net debt | 1,838 | 1,793 | 2,241 | 2,091 |
| Ratios and per share | ||||
| EBITDA margin | 24.4% | 25.4% | 24.4% | 21.3% |
| Profit margin | 13.2% | 12.4% | 11.0% | 8.2% |
| Return on equity | 20.3% | 17.9% | 16.3% | 10.6% |
| Earnings/share (NOK) | 8.96 | 8.74 | 8.27 | 6.22 |
| Book value/share (NOK) | 44.13 | 48.76 | 50.64 | 58.69 |
| Shares outstanding (M) | 100 | 100 | 100 | 100 |
From the annual statements (Yahoo Finance), in the currency the company reports in. Per-share figures use the shares at the year end. Charts and annual figures →
Quarterly figures from the reports
BetaFrom the company's own reports: 49 reports read by AI, every figure checked against the report's page and arithmetic.
Source: the 2ND QUARTER 2026 report, page 15, published 2026-07-16.
| Quarter | Revenue | Operating profit | Profit | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q2 2026 | 2,114 | 337 | −127 | −1.27 | … | 2ND QUARTER 2026, p. 15 |
| Q4 2025 | 1,833 | 249 | −81 | −0.81 | … | 4TH QUARTER 2025, p. 15 |
| Q3 2025 | 1,799 | 293 | 195 | 1.96 | … | 3RD QUARTER 2025, p. 14 |
| Q2 2025 | 9 | 11 | 4 | 0.04 | … | 2ND QUARTER 2026, p. 15 |
| Q1 2025 | 2,036 | 367 | 251 | 2.52 | … | Q1 2025, p. 13 |
| Q4 2024 | 1,744 | 216 | 129 | 1.30 | … | Q4 2024, p. 14 |
| Q3 2024 | 1,949 | 385 | 250 | 2.51 | … | 3RD QUARTER 2024, p. 13 |
| Q2 2024 | −26 | 66 | 44 | 0.44 | … | Q2 2024, p. 15 |
| Q1 2024 | 1,975 | 308 | 200 | 2.01 | … | 1ST QUARTER 2024, p. 12 |
| Q4 2023 | 1,605 | 192 | −520 | 1.19 | … | 1ST QUARTER 2024, p. 12 |
| Q3 2023 | 1,714 | 360 | 237 | 2.38 | … | 3RD QUARTER 2024, p. 13 |
| Q2 2023 | 113 | 99 | 52 | 0.52 | … | Q2 2023, p. 14 |
Amounts in NOK million, EPS in NOK. Each quarter as first reported, as a backtest would have seen it. Adjusted EPS (without one-off items) is shown once the one-off items have been checked against the companies' own adjusted figures.
One-off items in the reports
- 2026-06-30 Impairment loss on equity investment in Alginor and convertible loans, recognised in net financial items (share of loss from associates): −337.0 NOK million (Q2 2026, p. 4)
- 2026-06-30 Ground stabilisation measures at the Sarpsborg site (provision), booked in Other income and expenses, Q2 2026: −30.0 NOK million (Q2 2026, p. 4)
- 2025-12-31 Impairment of bio-based start-ups: +245.0 NOK million (4TH QUARTER 2025, p. 4)
- 2025-09-30 negative impact from the temporary disruption in cellulose production at the Sarpsborg site: +40.0 NOK million (3RD QUARTER 2025, p. 4)
- 2024-12-31 Other income and expenses: This accrual was for remediation of contaminated soil related to previously phased-out chlor-alkali technology at the Sarpsborg site.: −30.0 NOK million (Q4 2024, p. 4)
- 2024-03-31 Additional compensation for 2023: +5.0 NOK million (1ST QUARTER 2024, p. 13)
- 2023-12-31 negative impact from operational issues at the Sarpsborg site and increased global supply of synthetic vanillin and ethyl vanillin: −80.0 NOK million (Q4 2023, p. 4)
- 2023-09-30 Hedging effects: −62.0 NOK million (Q3 2023, p. 10)
Found by AI and still being validated: hover for the report's own words.
Sign in for free to open each report on the page a figure comes from.
Extracted by an AI model from the reports and can be wrong. Not investment advice.
Key figures
| P/E | 25.1 |
| P/B | 2.7 |
| EV / EBITDA | 10.9 |
| Net debt / EBITDA | 1.3 |
| Return on equity | 10.6% |
| Profit margin | 8.2% |
| Beta 1Y | 0.14 |
| Revenue growth 1Y | +1.0% |
| Revenue CAGR 3Y | +3.8% |
| Earnings/share CAGR 3Y | −11.5% |
| ROE avg. 3Y | 14.9% |
Ratios use the latest annual report that was public 90 days after the year end.
Dividends per share (NOK)
| 2026 | 4.75 |
| 2025 | 4.25 |
| 2024 | 3.75 |
| 2023 | 3.25 |
| 2022 | 5.00 |
Not investment advice. Figures may contain errors from the data source.